| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 395,014 | 458,387 | 483,537 | 488,246 | | Cost of Revenue | 149,907 | 165,331 | 177,407 | 176,506 | | | Gross Profit | 245,107 | 293,056 | 306,130 | 311,740 | | | Operating Expenses | | Research Development | 88,190 | 86,967 | 89,501 | 90,734 | | Selling General and Administrative | 77,652 | 85,032 | 88,080 | 93,004 | | Non Recurring |
-
|
-
| 2,487 | 19,536 | | Others | 1,006 | 1,475 | 1,426 | 1,425 | | | | Total Operating Expenses |
-
|
-
| 181,494 | 204,699 | | | | Operating Income or Loss | 78,259 | 119,582 | 124,636 | 107,041 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24,159 | 76,881 | (12,511) | 9,084 | | Earnings Before Interest And Taxes | 102,418 | 196,463 | 112,125 | 116,125 | | Interest Expense | 5,623 | 7,324 | 8,000 | 8,000 | | Income Before Tax | 96,795 | 189,139 | 104,125 | 108,125 | | Income Tax Expense | 26,283 | 49,765 | 22,300 | 24,196 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 70,512 | 139,374 | 81,825 | 83,929 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 70,512 | 139,374 | 81,825 | 83,929 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $70,512 | $139,374 | $81,825 | $83,929 |
|
0.45% Nasdaq 
0.20%
Income Statement
